Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
IFN-γ protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism
Karl-Johan Malmberg, … , Jelena Levitskaya, Rolf Kiessling
Karl-Johan Malmberg, … , Jelena Levitskaya, Rolf Kiessling
Published November 15, 2002
Citation Information: J Clin Invest. 2002;110(10):1515-1523. https://doi.org/10.1172/JCI15564.
View: Text | PDF
Article Immunology

IFN-γ protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism

  • Text
  • PDF
Abstract

Research Article

Authors

Karl-Johan Malmberg, Victor Levitsky, Håkan Norell, Cristina Teixeira de Matos, Mattias Carlsten, Kjell Schedvins, Hodjattallah Rabbani, Alessandro Moretta, Kalle Söderström, Jelena Levitskaya, Rolf Kiessling

×

Figure 4

Options: View larger image (or click on image) Download as PowerPoint
Expression of nonclassical HLA molecules. (a) The expression of HLA-E mR...
Expression of nonclassical HLA molecules. (a) The expression of HLA-E mRNA was evaluated in indicated OVACs by real-time quantitative PCR assay. Results are presented as fold increase in IFN-γ–treated cells (IFN) compared with untreated cells (NT). Results from one of two experiments are shown. (b) The expression of HLA-G by freshly isolated ovarian tumor cells was monitored by flow cytometry analysis. Indicated cells were stained with isotype control (mouse IgG2a) (solid line) or anti–HLA-G1 (87G) (dotted line). Results from one representative staining of at least ten are shown. (c) Western blot analysis of HLA-G expression in indicated OVACs and Caov-4 was performed using the HLA-G–specific mAb MEM-G/1 at a concentration of 1 μg/ml. The LCLs 721.221 and 721.221 transfected with HLA-G1 (721.221/G1) were used as positive and negative controls. These were diluted 1:10 because of the excess amount of HLA-G expressed by the 721.221/G1 transfectant. Cell extracts of untreated and IFN-γ–treated samples were loaded in equal amounts as determined by Western blots for β-actin (data not shown).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts